Sex differences in risk of cardiovascular disease in participants with cardiovascular-kidney-metabolic syndrome stages 0–3: parallel analyses of two prospective cohorts
The preclinical stages of Cardiovascular-Kidney-Metabolic (CKM) syndrome serve as an important surveillance window for cardiovascular disease (CVD) risk assessment and prevention. However, whether sex-specific differences in CVD risk exist across the CKM syndrome stages 0–3, and whether these differences would va...